In Vitro and In Vivo Activities of Gatifloxacin against Mycobacterium tuberculosis

Gatifloxacin (GAT) and moxifloxacin (MXF) were evaluated in vitro to determine their activities against Mycobacterium tuberculosis. GAT was subsequently compared in a dose range study to isoniazid (INH) in a murine tuberculosis model. GAT was somewhat less active than INH. GAT and MXF were evaluated...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Alvirez-Freites, Enrique J., Carter, Janna L., Cynamon, Michael H.
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 2002
Témata:	Experimental Therapeutics
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127120/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11897584/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.4.1022-1025.2002
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!